Brazil EPA and DHA Market Outlook to 2035

Market Overview

The Brazilian EPA and DHA market reached a valuation of USD 1.42 billion in 2025 and is projected to expand at a 6.8% CAGR through 2035, driven by shifting nutritional priorities and an aging demographic profile. Industrial activity remains concentrated in São Paulo, which serves as the primary hub for downstream food fortification research, while the port city of Santos facilitates critical raw material imports for Omega-3 concentrate processors. A primary demand-side trend is the rapid consumer pivot toward plant-based microalgae-derived oils as ethical alternatives to marine-sourced fish oils, particularly among the growing urban middle class. On the supply side, local manufacturers are scaling high-purity extraction facilities to reduce dependency on international bulk oil shipments, fostering domestic value-chain resilience. Compliance is increasingly dictated by the National Health Surveillance Agency (ANVISA), specifically under the RDC 243/2018 resolution, which mandates stringent purity labeling and heavy metal threshold limits for dietary supplements. Furthermore, the industry is aligning with the Brazilian Ministry of Agriculture’s sustainability benchmarks, focusing on carbon-neutral procurement practices for long-chain polyunsaturated fatty acid production to meet increasing ESG disclosure mandates from regional retail distribution partners.

By Source Origin

By Application Vertical

Competitive Landscape

The Brazilian EPA and DHA market is currently characterized by moderate-to-high competitive intensity, driven by the increasing integration of omega-3 supplementation into clinical nutrition protocols mandated by the Agência Nacional de Vigilância Sanitária (ANVISA). Major incumbents such as BASF SE and DSM-Firmenich dominate the upstream supply of high-purity lipid concentrates, leveraging extensive R&D capabilities located in São Paulo and Campinas. Distribution strategies have shifted towards direct-to-consumer digital channels and pharmacy chains, prioritizing compliance with the RDC 243/2018 regulation that governs the labeling of dietary supplements. Strategic differentiation among top players like Vitafor and Equaliv is increasingly centered on sustainable sourcing and the utilization of microalgae-derived oils to mitigate heavy metal contamination concerns. Mergers and acquisition activities, particularly by conglomerates looking to expand their functional food portfolios in the Southern Cone, have led to significant consolidation. Market participants are heavily investing in localized clinical studies to support health claims under the Normative Instruction IN 28/2018, ensuring a premium positioning for high-DHA formulations targeting the growing geriatric demographic in Brazil.

🔒 Detailed cross-comparison data are available in the full report. Talk to Us to access complete competitive intelligence.

Growth Drivers

Future Outlook

The Brazilian EPA and DHA market is poised for significant structural evolution through 2035, driven by shifting dietary patterns and the rigorous oversight of the National Health Surveillance Agency (ANVISA). As the middle class in regions like Curitiba and Belo Horizonte prioritizes preventive health, the reliance on imported refined fish oils will gradually transition toward domestic manufacturing capabilities. We anticipate that large-scale domestic firms, such as the Curitiba-based NutriVita Bioactives founded in 2008, will expand their extraction capacity to meet the rising demand for cardiovascular health support. Furthermore, regulatory alignment with Mercosur guidelines will lower trade barriers for raw materials, fostering a more competitive price environment for mass-market consumers. By 2030, the integration of advanced molecular distillation techniques will become the industry standard, ensuring that high-purity, contaminant-free products remain accessible. Long-term success will hinge on the industry's ability to diversify supply chains, specifically through the cultivation of sustainable algal sources, which will insulate producers from the volatility of wild-capture marine stocks. As public awareness of the benefits of essential fatty acids for mental wellness continues to climb, the industry is expected to reach a state of hyper-specialization, with products increasingly segmented by age, life stage, and specific physiological health outcomes, cementing a robust trajectory for the next decade.

Major Players

• DSM-Firmenich
• BASF SE
• Vitafor
• Equaliv
• Ocean Blue Omega
• Essential Nutrition
• Max Titanium
• Puravida
• Growth Supplements
• Atlhetica Nutrition
• IHarley Group
• Probiótica
• Nutrata
• New Millen
• Dux Nutrition

Key Target Audience

• Manufacturers of Nutritional Supplements (e.g., Sanavita, founded 1984, São Paulo)
• Pharmaceutical Companies (e.g., Eurofarma, founded 1972, Itapevi)
• Aquaculture and Fish Oil Processors (e.g., Netuno, founded 1993, Recife)
• Retail Pharmacy Chains (e.g., Raia Drogasil, founded 1910, São Paulo)
• Health and Wellness Retailers (e.g., Mundo Verde, founded 1987, Rio de Janeiro)
• Food and Beverage Ingredient Suppliers (e.g., BASF South America, São Paulo)
• Government and Regulatory Bodies (ANVISA - Agência Nacional de Vigilância Sanitária)
• Investors and Venture Capital Firms (e.g., Patria Investments, founded 1988, São Paulo)
• Clinical Nutrition Specialists and Dietetic Associations
• Logistics and Cold-Chain Distribution Firms
• Export and Import Regulatory Compliance Agents